Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

The rising consumption of processed foods raises serious health concerns, including increased risks of infertility and cancer ...

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could unlock safer and more effective cancer treatments, according to Virginia Tech ...

In an astounding breakthrough, scientists have discovered a molecular 'switch' that can revert cancer cells back into healthy ...

Scientists have translated nanoscale experimental and computational data into precise 3D representations of bacteria, yeast ...

Almost every one of us has either been diagnosed ourselves or had a relative diagnosed with cancer. I’ve been lucky enough to stay cancer free, but I’ve had several people close to me ...

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Therapeutic vaccines help the immune system seek and destroy cancer cells by targeting specific tumor DNA A small phase 1 ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...